Chengdu, China

Zejin You

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 14.0

ph-index = 2

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2018-2021

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: **Zejin You: Innovator in Biopharmaceuticals**

Introduction

Zejin You is a notable inventor based in Chengdu, China, recognized for his contributions to the field of biopharmaceuticals. With two patents to his name, he has been at the forefront of innovative drug development, particularly in the area of Janus kinase inhibitors.

Latest Patents

One of Zejin's latest patents is focused on an azetidine derivative, which serves as a Janus kinase (JAK) inhibitor. This innovative drug composition is aimed at treating various JAK-related diseases, including inflammatory diseases, autoimmune diseases, and certain types of cancers. This invention represents a significant advancement in therapeutic strategies for complex health issues.

Career Highlights

Zejin is currently employed at Sichuan Kelun Biotech Biopharmaceutical Co., Ltd., a leading company in the biopharmaceutical sector. His work at this organization has solidified his reputation as a prominent inventor in his field, driving research and development efforts that align with emerging medical needs.

Collaborations

Zejin collaborates with a talented team of professionals, including his coworkers Yinong Xie and Zhiwen Deng. Together, they contribute to advancing innovative biopharmaceutical solutions, leveraging their combined expertise to tackle some of the most pressing medical challenges.

Conclusion

Through his innovative work and dedication to biopharmaceutical research, Zejin You continues to make a meaningful impact in the medical field. His contributions not only enhance treatment options for patients but also inspire future developments in biopharmaceutical innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…